CN106377631A - Western medicine composition for preventing and treating pimples - Google Patents

Western medicine composition for preventing and treating pimples Download PDF

Info

Publication number
CN106377631A
CN106377631A CN201611032251.3A CN201611032251A CN106377631A CN 106377631 A CN106377631 A CN 106377631A CN 201611032251 A CN201611032251 A CN 201611032251A CN 106377631 A CN106377631 A CN 106377631A
Authority
CN
China
Prior art keywords
parts
western medicine
paste
emulsifiable paste
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201611032251.3A
Other languages
Chinese (zh)
Inventor
不公告发明人
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhengzhou Renhong Pharmaceutical Technology Co Ltd
Original Assignee
Zhengzhou Renhong Pharmaceutical Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhengzhou Renhong Pharmaceutical Technology Co Ltd filed Critical Zhengzhou Renhong Pharmaceutical Technology Co Ltd
Priority to CN201611032251.3A priority Critical patent/CN106377631A/en
Publication of CN106377631A publication Critical patent/CN106377631A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125—Camphor; Nuclear substituted derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/233—Bupleurum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Insects & Arthropods (AREA)
  • Dermatology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a Western medicine composition for preventing and treating pimples. The composition is composed of the following raw materials in parts by weight: 5-8 parts of oxytetracycline tablets, 3-5 parts of analgin tablets, 5-8 parts of bupleurum injection, 3-5 parts of compound dexamethasone acetate cream, 3-10 parts of fluocinonide ointment, 4-6 parts of loratadine tablets, 0.5-2 parts of tretinoin, 1-3 parts of panax notoginseng saponins, 5-10 parts of honey, 1-3 parts of aloe vera gel, 2-5 parts of miconazole nitrate cream, 5-10 parts of rapeseed oil and 1-3 parts of amprenavir. According to the Western medicine composition, the raw materials are complexed to achieve a synergistic effect, and the effects of effectively inhibiting growth of acnes, promoting anti-inflammatory recovery of acnes, effectively removing acne marks and promoting skin regeneration can be achieved; and moreover, the adopted raw materials are readily available, low in cost, good in curative effect, convenient to apply and small in toxic and side effects. In addition, the Western medicine composition is applied to normal skin, so that the skin is smooth and elastic.

Description

A kind of Western medicine compound of prevention and treatment comedo
Technical field
The present invention relates to a kind of Western medicine compound treating comedo, specifically a kind of Western medicine of prevention and treatment comedo Compositionss.
Background technology
Acne is commonly called as comedo, is a kind of pilosebaceous infective inflammation, is opened on follicular orifice sebaceous gland more, once Follicular orifice blocks, the acne of hyper-proliferative in the stimulation of excess fat acid that excessive sebum metabolism produces and enclosed environment The effect of propionibacterium, makes skin create inflammatory reaction, therefore the clinical manifestation of small pox from light to be again hoary hair's blackhead, Inflamed papules and pustule, cyst and tuberosity, and the rubescent small pox with suppuration is with the presence of bacterium infection.Acne is mainly apt to occur in Teenager, very big to teen-age psychology and social influence, but tend to nature after adolescence and mitigate or fully recover.
Existing Therapeutic Method mainly includes following several：
(1) local topical medicine：Tretinoin (tretinoin emulsifiable paste, Adapalene Gel, Tazarotene gel), benzoyl peroxide Formyl, antibioticses (clindamycin, erythromycin, chloromycetin etc.), Azelaic Acid, sulfur lotion etc..
(2) oral antibiotic：First-selected Tetracyclines (minocycline, doxycycline etc.), are secondly that Macrolide is (red mould Element), it is to avoid select to be usually used in the antibiotic such as levofloxacin magnitude for the treatment of system infection.Usual 6～12 weeks of antibiotic regimen.
(3) oral isotretinoin：For serious acne, oral isotretinoin is standard treatment, is also to treat acne at present Most efficient method.The course for the treatment of is to reach minimum accumulated dose 60mg/kg as target.
(4) anti-androgen therapy：As oral contraceptive Compound Cyproterone Acetate Tablets it is adaptable in women, severe acne Patient, with the too high performance of androgen levels (as hirsutism, seborrhea etc.) or polycystic ovarian syndrome.Delayed acne and the moon The female patient that before menstrual period, acne significantly increases also contemplates for applying oral contraceptive.
(5) oral glucocorticoid：It is mainly used in fulminant or acne conglobata, it then follows short-term, low dose and its other party The principle of method use in conjunction.
(6) other：For the patient not being resistant to or be reluctant to accept Drug therapy it is also contemplated that naturopathy, such as light move Power therapy (PDT), fruit acid therapy, laser therapy etc..
Existing Therapeutic Method still has that therapeutic effect is poor, the shortcoming for the treatment of cycle length, and some prices are higher, increases Add the financial burden of people.The medicine of various treatment acnes is also occurred in that on market, but effect is very different, has There is also serious complication and side effect, have impact on the healthy of people.Therefore, the present invention provides a kind of curative effect The Western medicine compound good, instant effect, toxic and side effects are little, price is relatively low.
Content of the invention
It is an object of the invention to provide a kind of Western medicine compound of prevention and treatment comedo, to solve above-mentioned background skill The problem proposing in art.
For achieving the above object, the present invention provides following technical scheme：
A kind of Western medicine compound of prevention and treatment comedo, is made up of the raw material of following parts by weight：Hydroxytetracycline tablet 5-8 Part, analgin tablet 3-5 part, injection of Radix Bupleuri 5-8 part, compound dexamethason acetate emulsifiable paste 3-5 part, fluocinonide cream 3-10 Part, Loratadine Tablets 4-6 part, Retinoic acid 0.5-2 part, XUESAITONG PIAN 1-3 part, Mel 5-10 part, Aloe glue 1-3 part, miconazole breast Cream 2-5 part, Oleum Brassicae campestriss 5-10 part, amprenavir 1-3 part.
As the further scheme of the present invention：It is made up of the raw material of following parts by weight：6 parts of hydroxytetracycline tablet, analgin tablet 4.5 parts, 7 parts of injection of Radix Bupleuri, 4 parts of compound dexamethason acetate emulsifiable paste, 4.5 parts of fluocinonide cream, Loratadine Tablets 5 Part, 1 part of Retinoic acid, 1.5 parts of XUESAITONG PIAN, 8 parts of Mel, 1.5 parts of Aloe glue, 2.5 parts of miconazole emulsifiable paste, 7 parts of Oleum Brassicae campestriss, An Pu 2.5 parts of that Wei.
A kind of preparation method of the Western medicine compound of prevention and treatment comedo, preparation method is as follows：
A. hydroxytetracycline tablet, analgin tablet, injection of Radix Bupleuri, compound dexamethason acetate emulsifiable paste, vinegar are weighed by weight Sour FUQINGSONG RUGAO, Loratadine Tablets, Retinoic acid, XUESAITONG PIAN, Mel, Aloe glue, miconazole emulsifiable paste, amprenavir and Semen Allii Tuberosi Oil, standby；
C. hydroxytetracycline tablet, analgin tablet, XUESAITONG PIAN, Loratadine Tablets are pulverized last mix homogeneously, mixed Close powder；
D. by injection of Radix Bupleuri, compound dexamethason acetate emulsifiable paste, fluocinonide cream, miconazole emulsifiable paste, Mel, reed Luxuriant growth glue, Retinoic acid, amprenavir mix homogeneously, obtain mix paste；
When e. Oleum Brassicae campestriss being put into vessel in heating to 30-45 DEG C, above-mentioned mixed-powder is put with above-mentioned mix paste Enter mixing in container, be sufficiently stirred for, ultrasonic vibration 5-10min, obtain final product paste Western medicine compound.
As the present invention further scheme：When Oleum Brassicae campestriss are put into vessel in heating to 35 DEG C, by above-mentioned mixed powder Last and above-mentioned mix paste is put in container and is mixed, and is sufficiently stirred for, and ultrasonic vibration 8min obtains final product paste Western medicine compound.
Compared with prior art, the invention has the beneficial effects as follows：
This Western medicine compound passes through raw material and compounds performance synergism, can effectively suppress small pox growth, promote small pox to disappear Scorching recovery, can effectively remove acne print, promote skin regeneration；And the Western medicine compound of the present invention adopt raw material be easy to get, cost Low, good effect, smear conveniently, toxic and side effects little；In addition, being applied on normal skin with this Western medicine compound, skin can be made to become Obtain moist, flexible.
Specific embodiment
With reference to specific embodiment, the technical scheme of this patent is described in more detail.
Embodiment 1
A kind of Western medicine compound of prevention and treatment comedo, is made up of the raw material of following parts by weight：Hydroxytetracycline tablet 5 Part, 3 parts of analgin tablet, 5 parts of injection of Radix Bupleuri, 3 parts of compound dexamethason acetate emulsifiable paste, 3 parts of fluocinonide cream, chlorine thunder he 4 parts of stator, 0.5 part of Retinoic acid, 1 part of XUESAITONG PIAN, 5 parts of Mel, 1 part of Aloe glue, 2 parts of miconazole emulsifiable paste, 5 parts of Oleum Brassicae campestriss, An Pu 1 part of that Wei.
A kind of preparation method of the Western medicine compound of prevention and treatment comedo, preparation method is as follows：
A. hydroxytetracycline tablet, analgin tablet, injection of Radix Bupleuri, compound dexamethason acetate emulsifiable paste, vinegar are weighed by weight Sour FUQINGSONG RUGAO, Loratadine Tablets, Retinoic acid, XUESAITONG PIAN, Mel, Aloe glue, miconazole emulsifiable paste, amprenavir and Semen Allii Tuberosi Oil, standby；
C. hydroxytetracycline tablet, analgin tablet, XUESAITONG PIAN, Loratadine Tablets are pulverized last mix homogeneously, mixed Close powder；
D. by injection of Radix Bupleuri, compound dexamethason acetate emulsifiable paste, fluocinonide cream, miconazole emulsifiable paste, Mel, reed Luxuriant growth glue, Retinoic acid, amprenavir mix homogeneously, obtain mix paste；
When e. Oleum Brassicae campestriss being put into vessel in heating to 30 DEG C, above-mentioned mixed-powder and above-mentioned mix paste are put into appearance Mix in device, be sufficiently stirred for, ultrasonic vibration 5min, obtain final product paste Western medicine compound.
Embodiment 2
A kind of Western medicine compound of prevention and treatment comedo, is made up of the raw material of following parts by weight：Hydroxytetracycline tablet 8 Part, 5 parts of analgin tablet, 8 parts of injection of Radix Bupleuri, 5 parts of compound dexamethason acetate emulsifiable paste, 10 parts of fluocinonide cream, chlorine thunder His 6 parts of stator, 2 parts of Retinoic acid, 3 parts of XUESAITONG PIAN, 10 parts of Mel, 3 parts of Aloe glue, 5 parts of miconazole emulsifiable paste, 10 parts of Oleum Brassicae campestriss, peace 3 parts of Pune's Wei.
A kind of preparation method of the Western medicine compound of prevention and treatment comedo, preparation method is as follows：
A. hydroxytetracycline tablet, analgin tablet, injection of Radix Bupleuri, compound dexamethason acetate emulsifiable paste, vinegar are weighed by weight Sour FUQINGSONG RUGAO, Loratadine Tablets, Retinoic acid, XUESAITONG PIAN, Mel, Aloe glue, miconazole emulsifiable paste, amprenavir and Semen Allii Tuberosi Oil, standby；
C. hydroxytetracycline tablet, analgin tablet, XUESAITONG PIAN, Loratadine Tablets are pulverized last mix homogeneously, mixed Close powder；
D. by injection of Radix Bupleuri, compound dexamethason acetate emulsifiable paste, fluocinonide cream, miconazole emulsifiable paste, Mel, reed Luxuriant growth glue, Retinoic acid, amprenavir mix homogeneously, obtain mix paste；
When e. Oleum Brassicae campestriss being put into vessel in heating to 45 DEG C, above-mentioned mixed-powder and above-mentioned mix paste are put into appearance Mix in device, be sufficiently stirred for, ultrasonic vibration 10min, obtain final product paste Western medicine compound.
Embodiment 3
A kind of Western medicine compound of prevention and treatment comedo, is made up of the raw material of following parts by weight：Hydroxytetracycline tablet 6 Part, 4.5 parts of analgin tablet, 7 parts of injection of Radix Bupleuri, 4 parts of compound dexamethason acetate emulsifiable paste, 4.5 parts of fluocinonide cream, chlorine His 5 parts of stator of thunder, 1 part of Retinoic acid, 1.5 parts of XUESAITONG PIAN, 8 parts of Mel, 1.5 parts of Aloe glue, 2.5 parts of miconazole emulsifiable paste, Oleum Brassicae campestriss 7 parts, 2.5 parts of amprenavir.
A kind of preparation method of the Western medicine compound of prevention and treatment comedo, preparation method is as follows：
A. hydroxytetracycline tablet, analgin tablet, injection of Radix Bupleuri, compound dexamethason acetate emulsifiable paste, vinegar are weighed by weight Sour FUQINGSONG RUGAO, Loratadine Tablets, Retinoic acid, XUESAITONG PIAN, Mel, Aloe glue, miconazole emulsifiable paste, amprenavir and Semen Allii Tuberosi Oil, standby；
C. hydroxytetracycline tablet, analgin tablet, XUESAITONG PIAN, Loratadine Tablets are pulverized last mix homogeneously, mixed Close powder；
D. by injection of Radix Bupleuri, compound dexamethason acetate emulsifiable paste, fluocinonide cream, miconazole emulsifiable paste, Mel, reed Luxuriant growth glue, Retinoic acid, amprenavir mix homogeneously, obtain mix paste；
When e. Oleum Brassicae campestriss being put into vessel in heating to 35 DEG C, above-mentioned mixed-powder and above-mentioned mix paste are put into appearance Mix in device, be sufficiently stirred for, ultrasonic vibration 8min, obtain final product paste Western medicine compound.
Comparative example 1
A kind of Western medicine compound of prevention and treatment comedo, is made up of the raw material of following parts by weight：Hydroxytetracycline tablet 6 Part, 4.5 parts of analgin tablet, 7 parts of injection of Radix Bupleuri, 4 parts of compound dexamethason acetate emulsifiable paste, 4.5 parts of fluocinonide cream, chlorine His 5 parts of stator of thunder, 1 part of Retinoic acid, 1.5 parts of XUESAITONG PIAN, 8 parts of Mel, 1.5 parts of Aloe glue, 2.5 parts of miconazole emulsifiable paste, Oleum Brassicae campestriss 7 parts.
A kind of preparation method of the Western medicine compound of prevention and treatment comedo, preparation method is as follows：
A. hydroxytetracycline tablet, analgin tablet, injection of Radix Bupleuri, compound dexamethason acetate emulsifiable paste, vinegar are weighed by weight Sour FUQINGSONG RUGAO, Loratadine Tablets, Retinoic acid, XUESAITONG PIAN, Mel, Aloe glue, miconazole emulsifiable paste and Oleum Brassicae campestriss, standby；
C. hydroxytetracycline tablet, analgin tablet, XUESAITONG PIAN, Loratadine Tablets are pulverized last mix homogeneously, mixed Close powder；
D. by injection of Radix Bupleuri, compound dexamethason acetate emulsifiable paste, fluocinonide cream, miconazole emulsifiable paste, Mel, reed Luxuriant growth glue, Retinoic acid mix homogeneously, obtain mix paste；
When e. Oleum Brassicae campestriss being put into vessel in heating to 35 DEG C, above-mentioned mixed-powder and above-mentioned mix paste are put into appearance Mix in device, be sufficiently stirred for, ultrasonic vibration 8min, obtain final product paste Western medicine compound.It is not added with amprenavir in comparative example 1.
The theoretical basiss of the present invention are：
Hydroxytetracycline tablet：Indication：Rickettsiosiss, including epidemic typhuses, endemic typhuss, Rocky Mountain Heat, scrub typhus and Q heat；Mycoplasma Infections；Chlamydia infections, including psittacosis, sexually transmitted disease (STD), lymph granuloma, non-specificity Urethritiss, salpingitis, cervicitises and trachoma；Relapsing fever；Gibraltar fever；Cholera；Tularemia；The plague；Chancroid.
Analgin tablet：It is mainly used in bringing down a fever, be also used for treating acute arthritises, headache, rheumatic pain, toothache and myalgia Deng.
Injection of Radix Bupleuri：Mainly there is antipyretic, antiinflammatory, strengthen the effect such as immune function.
Compound dexamethason acetate emulsifiable paste：For local pruritus, neurodermatitiss, contact dermatitis, seborrheica skin Inflammation and chronic eczema.
Fluocinonide cream：External is applied to the effective dermatosiss to glucocorticoid, such as contact dermatitis, atopy Dermatitis, seborrheic dermatitis, eczema, skin prurituss, psoriasises, neurodermatitiss etc. are pruritic and non-infectious inflammation skin Disease.
Loratadine Tablets：For seasonal or catarrhus perennialises, the urticaria being caused by anaphylactogen and skin scabies Itch.
Retinoic acid：For treat acne vulgariss, psoriasises, ichthyosiss, lichen planuss, pityriasis rubra pilaris, follicular keratosis, The disease such as squamous cell carcinoma and melanoma.
XUESAITONG PIAN：Blood circulation promoting and blood stasis dispelling, promotes blood circulation active, suppresses platelet aggregation and increases cerebral blood flow.
Mel：Looks improving and the skin nourishing.
Aloe glue：To incised wound, scratch, suppurating sore, scald, skin prurituss, comedo, black speck, mosquito bite, toothache, Labial angle festers, operative scar etc. has obvious assosting effect.
Miconazole emulsifiable paste：Miconazole is efficient, safety, broad-spectrum antifungal medicine, nearly all has effect to pathogenic funguses.
Amprenavir：Amprenavir is that a kind of new anti-reflective turns hiv protease inhibitor, has anti-HIV-1 and HIV-2 Albumen enzyme effect, can block protein precursor division, the growth course of viral interference necessary to HIV maturation, then discharge Immature do not have communicable viruses molecule.There is presently no the application finding amprenavir on treatment comedo.
Oleum Brassicae campestriss：Parasite killing can be moisturized, dissipate erysipelas, detumescence poison.
First, this Western medicine compound treats the observation of curative effect of small pox：
Clinical Selection small pox patient of the present invention 400, wherein man 170, female 230；Comedo patient 250, gets angry Small pox patient 50, physiology phase small pox patient 50, other 50.Small pox symptom is：Redness, pain, pustule, Whiteheads, Blackhead.Patient is divided into four groups, every group 100, respectively 1 group of embodiment, 2 groups of embodiment, 3 groups of embodiment and comparative example Group.
Application process：1 group of embodiment smears the Western medicine compound of the embodiment of the present invention 1 preparation daily, and 2 groups of embodiment is daily Smear the Western medicine compound of the embodiment of the present invention 2 preparation, 3 groups of embodiment smears the Western medicine group of the embodiment of the present invention 3 preparation daily Compound, comparative example group smears the Western medicine compound of comparative example 1 of the present invention preparation daily, 3 times a day, early, middle and late respectively smears one Secondary, clean after once keeping 15 minutes, be within 3 days a course for the treatment of.
The criterion of therapeutical effect of small pox：Effective, effective and invalid.
(1) effective：After smearing 1 course for the treatment of, small pox symptom is wholly absent, and skin recovers smooth, and no acne print produces, and one No recur in month；
(2) effective：After smearing 1 course for the treatment of, small pox symptom is clearly better, and small pox redness, pain, pustule disappear, and smear 2 After the course for the treatment of, small pox symptom is wholly absent, and skin recovers smooth, and no acne print produces；
(3) invalid：After smearing the 3-4 course for the treatment of, small pox symptom is no improved or is increased.
Therapeutic outcome is shown in Table 1：
This Western medicine compound of table 1 treats the efficacy result of small pox
Project Effective/example Effectively/example Invalid/example Effective percentage/%
1 group of embodiment 50 98 2 98
2 groups of embodiment 47 97 3 97
3 groups of embodiment 55 100 0 100
Comparative example group 20 65 35 65
Small pox can be effectively suppressed to grow, to small pox as it can be seen from table 1 this Western medicine compound passes through interpolation amprenavir Antiinflammatory recovers to play great role.And this Western medicine compound is respectively provided with higher effective percentage to treating various types of small poxs.
2nd, this Western medicine compound removes the observation of curative effect of acne print：
Clinical Selection patient of the present invention 200, is the acne print that small pox healing is formed；Wherein man 80, female 120.Will Patient is divided into two groups, i.e. treatment group and matched group, every group of 100 people.
Application process：Matched group smears the Western medicine compound of comparative example 1 preparation daily；It is real that treatment group smears the present invention daily Apply the Western medicine compound of example 3 preparation, 2-3 time on the one, clean after once keeping 20 minutes, be within 15 days a course for the treatment of.
Remove acne print criterion of therapeutical effect：Effective, effectively and invalid.
(1) effective：After 2 courses for the treatment of of treatment, at acne print, skin is moistened, no depression, projection, no small pox trace, stops treatment One month afterwards, no recur.
(2) effective：After 3 courses for the treatment of of treatment, at acne print, skin is moistened, and depression boss is inconspicuous, skin-color at acne print Close to surrounding normal skin, after treating 4 courses for the treatment of, acne print symptom is wholly absent in pool, stops latter month for the treatment of, no recurs.
(3) invalid：After 3 courses for the treatment of of treatment, acne print quality take a favorable turn, but stops symptom after treatment and restore.
Therapeutic outcome is shown in Table 2：
This Western medicine compound of table 2 removes the efficacy result of acne print
Group Case load Effective number of cases Effectively number of cases Invalid number of cases Total effective rate
Matched group 100 25 60 40 60%
Treatment group 100 55 95 5 95%
Table 2 shows, the Western medicine compound of the present invention passes through interpolation amprenavir and can be effectively increased the effective of removal acne print Rate, effective percentage reaches 95%, and this Western medicine compound is a kind of Western medicine compound that safely and effectively can remove acne print.
This Western medicine compound passes through raw material and compounds performance synergism, can effectively suppress small pox growth, promote small pox to disappear Scorching recovery, can effectively remove acne print, promote skin regeneration；And the Western medicine compound of the present invention adopt raw material be easy to get, cost Low, good effect, smear conveniently, toxic and side effects little；In addition, being applied on normal skin with this Western medicine compound, skin can be made to become Obtain moist, flexible.
Above the better embodiment of this patent is explained in detail, but this patent is not limited to above-mentioned embodiment party Formula, in the ken that one skilled in the relevant art possesses, can also be on the premise of without departing from this patent objective Make a variety of changes.

Claims (4)

1. a kind of Western medicine compound of prevention and treatment comedo is it is characterised in that be made up of the raw material of following parts by weight：Soil Mould plain piece 5-8 part, analgin tablet 3-5 part, injection of Radix Bupleuri 5-8 part, compound dexamethason acetate emulsifiable paste 3-5 part, acetic acid fluorine is light Loose emulsifiable paste 3-10 part, Loratadine Tablets 4-6 part, Retinoic acid 0.5-2 part, XUESAITONG PIAN 1-3 part, Mel 5-10 part, Aloe glue 1-3 Part, miconazole emulsifiable paste 2-5 part, Oleum Brassicae campestriss 5-10 part, amprenavir 1-3 part.
2. the Western medicine compound of prevention and treatment comedo according to claim 1 is it is characterised in that by following weight portion The raw material composition of number：6 parts of hydroxytetracycline tablet, 4.5 parts of analgin tablet, 7 parts of injection of Radix Bupleuri, 4 parts of compound dexamethason acetate emulsifiable paste, 4.5 parts of fluocinonide cream, 5 parts of Loratadine Tablets, 1 part of Retinoic acid, 1.5 parts of XUESAITONG PIAN, 8 parts of Mel, 1.5 parts of Aloe glue, 2.5 parts of miconazole emulsifiable paste, 7 parts of Oleum Brassicae campestriss, 2.5 parts of amprenavir.
3. a kind of preparation method of the described Western medicine compound of prevention and treatment comedo as arbitrary in claim 1-2, it is special Levy and be, preparation method is as follows：
A. hydroxytetracycline tablet, analgin tablet, injection of Radix Bupleuri, compound dexamethason acetate emulsifiable paste, acetic acid fluorine are weighed by weight Easily emulsifiable paste, Loratadine Tablets, Retinoic acid, XUESAITONG PIAN, Mel, Aloe glue, miconazole emulsifiable paste, amprenavir and Oleum Brassicae campestriss, standby With；
C. hydroxytetracycline tablet, analgin tablet, XUESAITONG PIAN, Loratadine Tablets are pulverized last mix homogeneously, obtain mixed powder End；
D. by injection of Radix Bupleuri, compound dexamethason acetate emulsifiable paste, fluocinonide cream, miconazole emulsifiable paste, Mel, Aloe Glue, Retinoic acid, amprenavir mix homogeneously, obtain mix paste；
When e. Oleum Brassicae campestriss being put into vessel in heating to 30-45 DEG C, above-mentioned mixed-powder and above-mentioned mix paste are put into appearance Mix in device, be sufficiently stirred for, ultrasonic vibration 5-10min, obtain final product paste Western medicine compound.
4. the preparation method of the Western medicine compound of prevention and treatment comedo according to claim 3 is it is characterised in that incite somebody to action When Oleum Brassicae campestriss put into vessel in heating to 35 DEG C, above-mentioned mixed-powder is put in container with above-mentioned mix paste and mixes, fill Divide stirring, ultrasonic vibration 8min, obtain final product paste Western medicine compound.
CN201611032251.3A 2016-11-22 2016-11-22 Western medicine composition for preventing and treating pimples Withdrawn CN106377631A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611032251.3A CN106377631A (en) 2016-11-22 2016-11-22 Western medicine composition for preventing and treating pimples

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611032251.3A CN106377631A (en) 2016-11-22 2016-11-22 Western medicine composition for preventing and treating pimples

Publications (1)

Publication Number Publication Date
CN106377631A true CN106377631A (en) 2017-02-08

Family

ID=57957637

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611032251.3A Withdrawn CN106377631A (en) 2016-11-22 2016-11-22 Western medicine composition for preventing and treating pimples

Country Status (1)

Country Link
CN (1) CN106377631A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1562140A (en) * 2004-04-14 2005-01-12 李训峰 Chinese-western combined medicine for treating burn and scald and other external wound
CN102552642A (en) * 2012-03-19 2012-07-11 屈广花 Medicine which is used for treating acnes of young people and has skin whitening effect and preparation method thereof
CN104056257A (en) * 2014-06-24 2014-09-24 谢一泓 Emulsifiable paste for treating acne

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1562140A (en) * 2004-04-14 2005-01-12 李训峰 Chinese-western combined medicine for treating burn and scald and other external wound
CN102552642A (en) * 2012-03-19 2012-07-11 屈广花 Medicine which is used for treating acnes of young people and has skin whitening effect and preparation method thereof
CN104056257A (en) * 2014-06-24 2014-09-24 谢一泓 Emulsifiable paste for treating acne

Similar Documents

Publication Publication Date Title
US8846646B2 (en) Topical treatment of skin infection
EP2961418B1 (en) Acne solution
CN112587446A (en) Composition for treating acne and preparation method and application thereof
JP4243353B2 (en) Zinc salt of conjugated linoleic acid for the treatment of skin diseases
CN113616575A (en) Composite azelaic acid emulsion for preventing allergy and removing acne and preparation method thereof
WO2017036241A1 (en) Acne-removing traditional chinese medicine composition and preparation method thereof
CN106389789A (en) Western medicine composition for preventing and treating acne and preparation method of western medicine composition
CN106377631A (en) Western medicine composition for preventing and treating pimples
CN106491876A (en) A kind of pharmaceutical composition of prevention and treatment comedo
US20200030398A1 (en) Skin care composition
귀영박 Pharmacological treatment options for acne
US20070207115A1 (en) Tea Tree Oil and Benzoyl Peroxide Acne Treatment
EP2588095B1 (en) Composition for the treatment of acne vulgaris
CN105342905A (en) Traditional Chinese medicinal facial mask
US20130316017A1 (en) Oral Composition for the Treatment of Acne
RU2705162C1 (en) Ointment for treating psoriasis (versions)
US9789078B2 (en) Method of topically treating actinic keratosis with ingenol mebutate cycle therapy
CN106214763A (en) A kind of traumatic injury Chinese drugs agentia
CN107998151B (en) Compound rehabilitation liquid liniment and preparation method thereof
CN104434946A (en) Compound drug for external use for treating acne
Paul Myrrh Oil's Role in Skincare: Effective Acne Management through Natural Remedies
CN106619751A (en) External medicine for treating tinea unguium
Walling Treatment options for the patient with acne vulgaris
CN117797232A (en) Traditional Chinese medicine composition for hand eczema
CN103285397A (en) External compound medicine for treating acne

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20170208